Focused on improving
patients’ lives
Peruvian company focused on improving access to healthcare
through innovative products and strategic services.
Driving innovation and transforming
healthcare in Peru
Our Approach
To be innovative, overcoming every challenge that comes
with it, in order to
become a benchmark in
healthcare across Latin
America.
We transform healthcare through
innovation and commitment.
Since 2005, we have developed and provided high-complexity therapies in oncology, hematology, infectious diseases, and
and multiple medical specialties, including
rare and orphan diseases. Our approach is base
research, timely access, and therapeutic quality, offering
healthcare professionals effective solutions aligned with
international standards of safety and efficacy.
Our Vision
To be a leading company in the Peruvian healthcare sector, recognized for our management capabilities, constant innovation, and commitment to providing access to high-value therapies...
Our Mision
To continuously contribute to improving the quality of life of patients in Peru through the responsible and timely distribution of medicines...
Our Values
Compliance,
Punctuality and respect,
Customer orientation,
Responsibility and commitment,
Development and innovation, Ongoing training...
“
We offer products for various therapeutic specialties
such as oncology, hematology, and infectious
diseases, as well as cell therapies, rare diseases, and
outsourced pharmaceutical services. Our commitment
is to provide safe, effective, and high-quality
medications, support physicians with innovative
therapies, and ensure patients have access to cutting
-edge treatments.
Dr. Leopoldo Valdez Castañeda
CEO Global Med Farma
Achievements that inspire and drive
us to keep moving forward
We have successfully laid the foundation for today’s new national programs.
Throughout our journey, at Global Med Farma we have driven tangible progress in public health — from supplying clotting factors for hemophilia and providing specialized technology for pediatric transplants, to introducing therapies for rare diseases. We are proud of the achievements that reflect our sustained commitment to delivering solutions that transform patient health in Peru.
Burosumab
In 2023, we introduced Crysvita®, the first and only monoclonal antibody
approved for the
treatment of X-linked
hypophosphatemic rickets.
Transplants
More than 72 haploidentical transplants in pediatric patients with
unrelated donors were made possible
thanks to our cell separation
products...
Supplying
For over 7 years, we were pioneers in
supplying clotting
factors for the
prophylactic treatmen of
A and B with in MINSA...
Consulting, Outsourcing,
and Business Development
Services
consulting, outsourcing, and business development services for the
pharmaceutical industry in Latin America and beyond. Our Executive Team brings
extensive experience in managing pharmaceutical businesses in the region, across
both multinational corporations and regionally focused companies.
- Pharmaceutical Hosting Services
- Advisory and Consulting Services in Regulatory Affairs
- Market Access Service
Our Units and
Services
We offer a wide range of products and
services distributed across different units.
Medical
Specialties
Unit
make it possible to meet
patients’ medical needs.
Medical
Orphan
Diseases Unit
Providing the opportunity to
access the most advanced
therapies in a timely manner.
Medical
Investigación
We have always focused on
improving patients’ lives through
highly effective and safe
alta eficacia y seguridad.
Unavailable
Medicines
Access Unit
We work continuously to
transform patients’ lives through
innovative and safe treatments.
Pharma
Business
Area
therapy solutions to optimize
bone marrow transplant procedures.